Skip to main content
Top
Published in: European Radiology 6/2017

01-06-2017 | Gastrointestinal

Technical feasibility and tissue reaction after silicone-covered biodegradable magnesium stent insertion in the oesophagus: a primary study in vitro and in vivo

Authors: Yue-Qi Zhu, Laura Edmonds, Li-Ming Wei, Rei-La Zheng, Ruo-Yu Cheng, Wen-Guo Cui, Ying-Sheng Cheng

Published in: European Radiology | Issue 6/2017

Login to get access

Abstract

Objectives

Determine the feasibility of and tissue response to biodegradable magnesium–silicone stent insertion into the oesophagus of rabbits.

Methods

Mechanical compression–recovery and degradation behaviours of the stents were investigated in vitro. Thirty rabbits were randomly divided into a magnesium–silicone stent group (n = 15) that received stent insertion into the lower 1/3 of the oesophagus under fluoroscopic guidance and a control group (n = 15). Oesophagography was performed at 1, 2 and 4 weeks. Five rabbits in each group were euthanized at each time point for histological examination.

Results

Magnesium–silicone stents showed good flexibility and elasticity, and degraded more slowly than bare stents at pH 4.0 and 7.4. All stent insertions were well tolerated. The oesophageal diameters at 1, 2 and 4 weeks were 9.7 ± 0.7, 9.6 ± 0.8 and 9.6 ± 0.5 mm, respectively (vs. 9.2 ± 0.8 mm before intervention; P > 0.05). Stent migration occurred in six rabbits (one at 1 week, one at 2 and four at 4). Microscopy demonstrated dilation of the oesophageal wall within 1 week of insertion. Oesophageal injury and collagen deposition following stent insertion were similar to control (P > 0.05).

Conclusions

Oesophageal magnesium–silicone stent insertion was feasible and provided reliable support for 2 weeks without causing oesophageal injury or collagen deposition.

Key Points

Mg stent provided apparently adequate radial force and silicone membrane reduced magnesium biodegradation
Stent insertion provided good support for at least 2 weeks before biodegradation
Stenting effectively resulted in oesophageal wall remodelling, without demonstrable injury.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferguson DD (2005) Evaluation and management of benign esophageal strictures. Dis Esophagus 18(6):359–64CrossRefPubMed Ferguson DD (2005) Evaluation and management of benign esophageal strictures. Dis Esophagus 18(6):359–64CrossRefPubMed
2.
go back to reference Choi EK, Song HY, Kim JW et al (2007) Covered metallic stent placement in the management of cervical esophageal strictures. J Vasc Interv Radiol 18:888–95CrossRefPubMed Choi EK, Song HY, Kim JW et al (2007) Covered metallic stent placement in the management of cervical esophageal strictures. J Vasc Interv Radiol 18:888–95CrossRefPubMed
3.
go back to reference Cheng YS, Li MH, Chen WX, Chen NW, Zhuang QX, Shang KZ (2003) Temporary partially-covered metal stent insertion in benign esophageal stricture. World J Gastroenterol 9:2359–61CrossRefPubMedPubMedCentral Cheng YS, Li MH, Chen WX, Chen NW, Zhuang QX, Shang KZ (2003) Temporary partially-covered metal stent insertion in benign esophageal stricture. World J Gastroenterol 9:2359–61CrossRefPubMedPubMedCentral
4.
go back to reference Schembre D, Dever JB, Glenn M et al (2011) Esophageal reconstitution by simultaneous antegrade/retrograde endoscopy: re-establishing patency of the completely obstructed esophagus. Endoscopy 43(5):434–7CrossRefPubMed Schembre D, Dever JB, Glenn M et al (2011) Esophageal reconstitution by simultaneous antegrade/retrograde endoscopy: re-establishing patency of the completely obstructed esophagus. Endoscopy 43(5):434–7CrossRefPubMed
5.
go back to reference Bick BL, Song LM, Buttar NS et al (2013) Stent-associated esophagorespiratory fistulas: incidence and risk factors. Gastrointest Endosc 77(2):181–9CrossRefPubMed Bick BL, Song LM, Buttar NS et al (2013) Stent-associated esophagorespiratory fistulas: incidence and risk factors. Gastrointest Endosc 77(2):181–9CrossRefPubMed
6.
go back to reference Stewart DJ, Balamurugan R, Everitt NJ et al (2013) Ten-year experience of esophageal self-expanding metal stent insertion at a single institution. Dis Esophagus 26(3):276–81CrossRefPubMed Stewart DJ, Balamurugan R, Everitt NJ et al (2013) Ten-year experience of esophageal self-expanding metal stent insertion at a single institution. Dis Esophagus 26(3):276–81CrossRefPubMed
8.
go back to reference Yim HB (2014) Self-expanding metallic stents and self-expanding plastic stents in the palliation of malignant oesophageal dysphagia. Ann Palliat Med 3:41–6PubMed Yim HB (2014) Self-expanding metallic stents and self-expanding plastic stents in the palliation of malignant oesophageal dysphagia. Ann Palliat Med 3:41–6PubMed
9.
go back to reference Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB (1998) In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 31:224–230CrossRefPubMed Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB (1998) In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 31:224–230CrossRefPubMed
10.
go back to reference Ferguson DD (2005) Evaluation and management of benign esophageal strictures. Dis Esophagus 18:359–364CrossRefPubMed Ferguson DD (2005) Evaluation and management of benign esophageal strictures. Dis Esophagus 18:359–364CrossRefPubMed
11.
go back to reference Na HK, Song HY, Kim JH et al (2013) How to design the optimal self-expandable oesophageal metallic stents: 22 years of experience in 645 patients with malignant strictures. Eur Radiol 23:786–96CrossRefPubMed Na HK, Song HY, Kim JH et al (2013) How to design the optimal self-expandable oesophageal metallic stents: 22 years of experience in 645 patients with malignant strictures. Eur Radiol 23:786–96CrossRefPubMed
12.
go back to reference Thomas T, Abrams KR, Subramanian V et al (2011) Esophageal stents for benign refractory strictures: a meta-analysis. Endoscopy 43(5):386–93CrossRefPubMed Thomas T, Abrams KR, Subramanian V et al (2011) Esophageal stents for benign refractory strictures: a meta-analysis. Endoscopy 43(5):386–93CrossRefPubMed
13.
go back to reference Tanaka T, Takahashi M, Nitta N et al (2006) Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial. Digestion 74(3-4):199–205CrossRefPubMed Tanaka T, Takahashi M, Nitta N et al (2006) Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial. Digestion 74(3-4):199–205CrossRefPubMed
14.
go back to reference Repici A, Vleggaar FP, Hassan C et al (2010) Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study. Gastrointest Endosc 72:927–34CrossRefPubMed Repici A, Vleggaar FP, Hassan C et al (2010) Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study. Gastrointest Endosc 72:927–34CrossRefPubMed
15.
go back to reference Pauli EM, Schomisch SJ, Furlan JP et al (2012) Biodegradable esophageal stent placement does not prevent high-grade stricture formation after circumferential mucosal resection in a porcine model. Surg Endosc 26:3500–8CrossRefPubMedPubMedCentral Pauli EM, Schomisch SJ, Furlan JP et al (2012) Biodegradable esophageal stent placement does not prevent high-grade stricture formation after circumferential mucosal resection in a porcine model. Surg Endosc 26:3500–8CrossRefPubMedPubMedCentral
16.
go back to reference Dumoulin FL, Plassmann D (2012) Tissue hyperplasia following placement of a biodegradable stent for a refractory esophageal stricture: treatment with argon plasma coagulation. Endoscopy 44(Suppl 2)UCTN:E356-7 Dumoulin FL, Plassmann D (2012) Tissue hyperplasia following placement of a biodegradable stent for a refractory esophageal stricture: treatment with argon plasma coagulation. Endoscopy 44(Suppl 2)UCTN:E356-7
17.
go back to reference Zhu YQ, Cui WG, Cheng YS et al (2013) Biodegradable rapamycin-eluting nano-fiber membrane-covered metal stent placement to reduce fibroblast proliferation in experimental stricture in a canine model. Endoscopy 45(6):458–68CrossRefPubMed Zhu YQ, Cui WG, Cheng YS et al (2013) Biodegradable rapamycin-eluting nano-fiber membrane-covered metal stent placement to reduce fibroblast proliferation in experimental stricture in a canine model. Endoscopy 45(6):458–68CrossRefPubMed
18.
go back to reference Zhu YQ, Cui WG, Cheng YS et al (2013) Evaluation of biodegradable paclitaxel-eluting nanofibre-covered metal stents for the treatment of benign cardia stricture in an experimental model. Br J Surg 100(6):784–93CrossRefPubMed Zhu YQ, Cui WG, Cheng YS et al (2013) Evaluation of biodegradable paclitaxel-eluting nanofibre-covered metal stents for the treatment of benign cardia stricture in an experimental model. Br J Surg 100(6):784–93CrossRefPubMed
19.
go back to reference Zhu YQ, Cheng YS, Li F et al (2011) Application of the newly developed stents in the treatment of benign cardia stricture: an experimental comparative study. Gastrointest Endosc 73(2):329–37CrossRefPubMed Zhu YQ, Cheng YS, Li F et al (2011) Application of the newly developed stents in the treatment of benign cardia stricture: an experimental comparative study. Gastrointest Endosc 73(2):329–37CrossRefPubMed
20.
go back to reference Gu XN, Zheng YF, Cheng Y et al (2009) In vitro corrosion and biocompatibility of binary magnesium alloys. Biomaterials 30(4):484–498CrossRefPubMed Gu XN, Zheng YF, Cheng Y et al (2009) In vitro corrosion and biocompatibility of binary magnesium alloys. Biomaterials 30(4):484–498CrossRefPubMed
21.
go back to reference Li X, Chu CL, Liu L et al (2015) Biodegradable poly-lactic acid based-composite reinforced unidirectionally with high-strength magnesium alloy wires. Biomaterials 49:135–44CrossRefPubMed Li X, Chu CL, Liu L et al (2015) Biodegradable poly-lactic acid based-composite reinforced unidirectionally with high-strength magnesium alloy wires. Biomaterials 49:135–44CrossRefPubMed
22.
go back to reference Wong HM, Yeung KW, Lam KO et al (2010) A biodegradable polymer-based coating to control the performance of magnesium alloy orthopaedic implants. Biomaterials 31(8):2084–96CrossRefPubMed Wong HM, Yeung KW, Lam KO et al (2010) A biodegradable polymer-based coating to control the performance of magnesium alloy orthopaedic implants. Biomaterials 31(8):2084–96CrossRefPubMed
23.
go back to reference Haude M, Erbel R, Erne P, Verheye S et al (2013) Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. Lancet 381(9869):836–44CrossRefPubMed Haude M, Erbel R, Erne P, Verheye S et al (2013) Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. Lancet 381(9869):836–44CrossRefPubMed
Metadata
Title
Technical feasibility and tissue reaction after silicone-covered biodegradable magnesium stent insertion in the oesophagus: a primary study in vitro and in vivo
Authors
Yue-Qi Zhu
Laura Edmonds
Li-Ming Wei
Rei-La Zheng
Ruo-Yu Cheng
Wen-Guo Cui
Ying-Sheng Cheng
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 6/2017
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4602-1

Other articles of this Issue 6/2017

European Radiology 6/2017 Go to the issue